In the last 12 months, GlaxoSmithKline plc (ADR) (NYSE:GSK) generated 20.78% using assets of the company. Reuters provide figures showing that industry's suggest 12.74% and broadly in sector 8.32% seems favorable.
GlaxoSmithKline plc. (ADR) (NYSE:GSK) announced it will invest $95 million to manufacture a new research institute in Seattle called Altius Institute for Biomedical Sciences, as the company looks to speed up new drugs discovery and development.
GlaxoSmithKline plc (ADR) (NYSE:GSK) has not been making the best decisions lately. The biotech giant is already facing significant pressure on earnings due to cheaper drug competition, a recent bribery scandal in China, and poor stock performance.
GlaxoSmithKline plc (ADR) (NYSE:GSK) reported first-quarter fiscal'15 (1QFY15) earnings yesterday, with CEO Andrew Witty providing investors a much-needed future outlook for the company stock and a detailed 2015 guidance.
GlaxoSmithKline plc (ADR) (NYSE:GSK) plans to report its first-quarter fiscal year 2015 (1QFY15) earnings data during market hours on May 6. Analysts expect the company's earnings to continue with their downward spiral, while they think a promising ...